Publicaciones en las que colabora con MARIA JOSEFA ALONSO FERNANDEZ (26)

2024

  1. Engineering hyaluronic acid-based nanoassemblies for monoclonal antibody delivery – design, characterization, and biological insights

    Nano Research, Vol. 17, Núm. 10, pp. 9111-9125

  2. Nanotechnology-assisted intracellular delivery of antibody as a precision therapy approach for KRAS-driven tumors

    Journal of Controlled Release, Vol. 373, pp. 277-292

2021

  1. A nanoemulsion/micelles mixed nanosystem for the oral administration of hydrophobically modified insulin

    Drug Delivery and Translational Research, Vol. 11, Núm. 2, pp. 524-545

  2. Correction to: A nanoemulsion/micelles mixed nanosystem for the oral administration of hydrophobically modified insulin (Drug Delivery and Translational Research, (2021), 11, 2, (524-545), 10.1007/s13346-021-00920-x)

    Drug Delivery and Translational Research

  3. Nanotechnologies for the delivery of biologicals: Historical perspective and current landscape

    Advanced Drug Delivery Reviews, Vol. 176

2017

  1. Advances on the formulation of proteins using nanotechnologies

    Journal of Drug Delivery Science and Technology, Vol. 42, pp. 155-180

  2. Modulating the immune system through nanotechnology

    Seminars in Immunology, Vol. 34, pp. 78-102

2015

  1. Enhanced in vivo therapeutic efficacy of plitidepsin-loaded nanocapsules decorated with a new poly-aminoacid-PEG derivative

    International Journal of Pharmaceutics, Vol. 483, Núm. 1-2, pp. 212-219

2014

  1. Polyglutamic acid-PEG nanocapsules as long circulating carriers for the delivery of docetaxel

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 87, Núm. 1, pp. 47-54

2013

  1. A new potential nano-oncological therapy based on polyamino acid nanocapsules

    Journal of Controlled Release, Vol. 169, Núm. 1-2, pp. 10-16

  2. Anti-tumor efficacy of chitosan-g-poly(ethylene glycol) nanocapsules containing docetaxel: Anti-TMEFF-2 functionalized nanocapsules vs. non-functionalized nanocapsules

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 83, Núm. 3, pp. 330-337

  3. Hyaluronan nanocapsules as a new vehicle for intracellular drug delivery

    European Journal of Pharmaceutical Sciences, Vol. 49, Núm. 4, pp. 483-490

  4. In vivo evaluation of poly-l-asparagine nanocapsules as carriers for anti-cancer drug delivery

    International Journal of Pharmaceutics, Vol. 458, Núm. 1, pp. 83-89

  5. Intracellular delivery of docetaxel using freeze-dried polysaccharide nanocapsules

    Journal of Microencapsulation, Vol. 30, Núm. 2, pp. 181-188

  6. Poly-l-asparagine nanocapsules as anticancer drug delivery vehicles

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 85, Núm. 3 PART A, pp. 481-487

  7. Polyarginine nanocapsules: A new platform for intracellular drug delivery

    Journal of Nanoparticle Research, Vol. 15, Núm. 3

2012

  1. A potential nanomedicine consisting of heparin-Loaded Polysaccharide Nanocarriers for the Treatment of Asthma

    Macromolecular Bioscience, Vol. 12, Núm. 2, pp. 176-183

2011

  1. A new drug nanocarrier consisting of polyarginine and hyaluronic acid

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 79, Núm. 1, pp. 54-57

  2. Nanocapsules as carriers for the transport and targeted delivery of bioactive molecules

    Nanocomposite Particles for Bio-Applications: Materials and Bio-Interfaces (Pan Stanford Publishing Pte. Ltd.), pp. 45-67

  3. Nanoterapias oncológicas: aplicaciones actuales y perspectivas futuras

    Anales de la Real Academia Nacional de Farmacia, Núm. 4, pp. 76-98